Alivus Life Sciences

1,055.40
+42.25
(4.17%)
Market Cap
12,932.12 Cr
EPS
38.43
PE Ratio
28.09
Dividend Yield
2.22 %
Industry
Healthcare
52 Week High
1,251.00
52 Week low
985.00
PB Ratio
4.89
Debt to Equity
0.01
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy100.00 %
100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
4.80 %
Net Income Growth
0.84 %
Cash Flow Change
35.13 %
ROE
-7.55 %
ROCE
-8.03 %
EBITDA Margin (Avg.)
-2.45 %

Yearly Financial Results

Annual Financials
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
0
887
1,549
1,886
2,138
2,190
2,295
2,302
Expenses
0
639
1,065
1,294
1,507
1,519
1,609
1,648
EBITDA
0
248
484
592
631
671
686
653
Operating Profit %
-5 %
28 %
31 %
31 %
29 %
30 %
30 %
27 %
Depreciation
0
19
29
33
38
42
54
59
Interest
0
1
34
88
28
1
2
2
Profit Before Tax
0
228
421
471
565
629
631
593
Tax
0
33
108
119
146
162
160
146
Net Profit
-0
196
313
352
419
467
471
442
EPS in ₹
-7.89
24.64
29.04
32.61
35.63
38.11
38.43
36.10

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
0
1,475
1,726
1,997
2,471
2,702
2,850
Fixed Assets
0
456
546
573
590
781
805
Current Assets
0
931
1,160
1,399
1,765
1,850
1,916
Capital Work in Progress
0
80
11
14
97
62
106
Investments
0
0
0
0
0
0
0
Other Assets
0
939
1,169
1,410
1,784
1,860
1,939
Total Liabilities
0
1,475
1,726
1,997
2,471
2,702
2,850
Current Liabilities
2
1,380
1,308
1,221
384
497
439
Non Current Liabilities
0
7
16
23
33
67
79
Total Equity
-1
88
402
753
2,054
2,138
2,332
Reserve & Surplus
-1
86
400
751
2,030
2,114
2,308
Share Capital
0
2
2
2
25
25
25

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
2
8
106
397
-228
18
Investing Activities
0
-9
-51
-69
-122
-147
-117
Operating Activities
-1
10
195
388
598
306
414
Financing Activities
1
1
-137
-214
-79
-388
-279

Share Holding

% Holding
Apr 2021
Aug 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
100.00 %
82.84 %
82.84 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
82.85 %
75.00 %
75.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.00 %
0.00 %
4.38 %
0.00 %
5.01 %
4.82 %
7.85 %
6.74 %
DIIs
0.00 %
1.34 %
0.30 %
0.32 %
0.50 %
0.71 %
0.79 %
0.09 %
0.00 %
0.58 %
0.64 %
0.59 %
1.40 %
1.57 %
4.16 %
4.86 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
7.99 %
7.97 %
7.72 %
7.80 %
8.14 %
9.14 %
9.77 %
10.87 %
10.02 %
9.20 %
9.20 %
9.09 %
9.13 %
10.63 %
10.99 %
Others
0.00 %
7.83 %
8.89 %
9.11 %
8.86 %
8.31 %
7.21 %
7.29 %
6.28 %
6.55 %
2.92 %
7.36 %
1.64 %
1.64 %
2.36 %
2.41 %
No of Share Holders
7
3,73,362
2,80,300
2,53,726
2,38,578
2,33,538
2,32,203
2,25,730
2,22,866
2,08,267
1,98,764
1,85,531
1,56,183
1,49,396
1,43,960
1,46,840

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Technical Indicators